Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 1 - 50 out of 10,593

Document Document Title
WO/2019/010414A1
This disclosure concerns fatty acid derivatives, pharmaceutical compositions comprising the fatty acid derivatives, and methods of using the fatty acid derivatives, for example, to treat inflammation, chronic itch, chronic pain, an autoi...  
WO/2019/008002A1
The invention relates to a composition comprising a) a polymer and b) (i) a phenolic metal salt of formula (I) Mn+ (L-)n wherein n is 1, 2 or 3, Mn+ is a metal ion and L- is an anion of formula (II) wherein A1 and A2 are both -CH2-CH2-, ...  
WO/2019/002189A1
The invention also relates to alkoxylated hydroxy carbon acids and to a method for the production and use thereof.  
WO/2018/236950A1
A method is provided for separating a dicarboxylic acid product from a mixture containing such dicarboxylic acids. The method involves: providing a dicarboxylic acid-containing mixture of which at least 35% of the carboxylic acid content...  
WO/2018/235012A1
Process for producing levulinic acid, wherein a carbohydrate-based substrate is subjected to a treatment step in aqueous environment at acid pH at a temperature from 120°C to 200°C, so as to obtain a reaction mixture comprising levulin...  
WO/2018/229013A1
The invention concerns a method for obtaining a free glucaric acid solution from a solution comprising non-free glucaric acid, water and at least one other constituent including at least one ion, characterised in that it comprises the fo...  
WO/2018/228149A1
The present invention belongs to the field of pharmaceutical synthesis, and relates to a preparation method for a substituted phenylacetic acid derivative, in particular to a method for preparing 2-[4-(2-oxopentylmethyl)phenylpropionic a...  
WO/2018/226102A1
The present invention is directed to methods for the preparation of eremophila-1(10)-11(13)-dien-12,8β-olide (EPD) and analogues thereof.  
WO/2018/222785A1
Porous calcium lactate metal-organic frameworks (MOFs) comprise non-toxic metal ions - Ca(II) and non-toxic, renewable and cheap linkers - lactate and acetate. The MOFs are nontoxic and environmentally-benign, and can be used as degradab...  
WO/2018/218963A1
Provided in the present invention are a pharmaceutically acceptable salt of an epidermal growth factor receptor (EGFR) inhibitor, a crystal form thereof, a preparation method therefor and an application thereof. The structural formula of...  
WO/2018/212624A1
The present invention relates to a 11-lipoxygenase consisting of the amino acid sequence represented by SEQ ID NO: 1; or a composition for producing 11-hydroxyfatty acid, hepoxilin D3, or trioxilin D3, comprising the 11-lipoxygenase and ...  
WO/2018/205037A1
The present description relates to genetic tools and methods to facilitate transformation and genetic engineering of industrially-useful yeast/fungal species, such as Issatchenkia orientalis, for which a robust set of genetic tools such ...  
WO/2018/195163A1
This present invention provides gemcabene pharmaceutically acceptable salts having a PSD90 of 35 µm to about 90 µm, methods for purifying crude gemcabene, pharmaceutically acceptable salts of purified gemcabene, pharmaceutical composit...  
WO/2018/195422A1
A process for a reactive separation of organic molecules from biomass includes a reaction step for the biomass, a simultaneous extraction step using a solvent, and a filtration step to recover products, wherein the products comprise feru...  
WO/2018/191275A1
Compositions and methods for making cDNA from RNA templates, including double-stranded RNA (dsRNA) and single-stranded RNA (ssRNA), are provided. The composition and methods include a recombinant or purified or modified or recombinant RN...  
WO/2018/187852A1
Compositions and methods for providing a person with an exogenous and therapeutically effective supply of ketones are disclosed. The compositions may consist essentially of (a) purified butyrate (or esters or propionate salts thereof) an...  
WO/2018/187148A1
The present invention relates to a process of making a compound of formula (I). Wherein, R is as defined herein.  
WO/2018/181847A1
The purpose of the present invention is to provide a novel aromatic compound capable of having GPR40 agonistic activity and activity in accelerating GLP-1 secretion. A compound represented by formula (I) (wherein the symbols are as defin...  
WO/2018/176150A1
Novel methods for isolating fish roe/egg extracts, notably a coagulum and a sediment extract, enriched in phospholipids and omega-3 fatty acids are described. Novel compositions comprising omega-3 polyunsaturated fatty acids and micronut...  
WO/2018/181907A1
Provided are a novel carbonyl group-containing sulfonic acid and carboxylic acid, and salts thereof. The present invention is a compound represented by the formula: R1-C(=O)-(CR2 2)n-(OR3)p-(CR4 2)q-L-A (In the formula, R1 is an optional...  
WO/2018/172062A1
A process for preparing an anticorrosion component for antifreeze by oxidation of an oxydiol (I) in which x is 0 (zero) or a positive integer from 1 to 10 with molecular oxygen at a temperature of 20 to 100°C and a partial oxygen pressu...  
WO/2018/175288A1
Provided are compounds, pharmaceutical compositions, cosmetic and dermatological compositions or nutritional supplement compositions, comprising omega-3 very-long-chain polyunsaturated fatty acids (n-3 VLC-PUFAs) and/or their endogenous ...  
WO/2018/164193A1
Provided is a catalyst characterized in that: a metal component containing a first component, which is rhenium, and one or more types of second components selected from a group consisting of silicon, gallium, germanium and indium is supp...  
WO/2018/161175A1
Methods and compositions for inhibiting or preventing neurodegeneration, specifically hippocampal, cortical, and/or retinal ganglion cell neurons (RGC), and degeneration and/or cell loss or treating related disorders and diseases compris...  
WO/2018/157225A1
Methods are provided for synthesis of abscisic acid and 8' analogues thereof (including an enantiopure 8'-acetylene analogue) including methods wherein the previously reported first step of oxidation of 2,6-dimethylphenol (VI) to 2,6- di...  
WO/2018/159560A1
The purpose of the present invention is to provide: a radiation-sensitive resin composition which has excellent LWR performance, resolution, rectangularity of a cross-sectional shape, depth of focus and film shrinkage suppressing propert...  
WO/2018/154314A1
A method of processing an aqueous hemicellulosic stream containing lignin, comprising: (a) contacting an aqueous hemicellulosic stream containing lignin with a C3-8 alkyl alcohol at elevated temperature and acidic pH; (b) separating the ...  
WO/2018/148816A4
The invention describes extracts from plants of the genus Stachytarpheta enriched with ipolamiide derivatives as immunosuppressants for treating immunological disorders. The isolated active compounds and a process of producing these are ...  
WO/2018/148816A3
The invention describes extracts from plants of the genus Stachytarpheta enriched with ipolamiide derivatives as immunosuppressants for treating immunological disorders. The isolated active compounds and a process of producing these are ...  
WO/2018/145553A1
The present disclosure provides co-crystals of a substituted glycine compound and a co-former compound of Formula (I), compositions comprising such, and uses thereof in treating and/or reducing the risk for a neuropsychiatricdisorder (e....  
WO/2018/144717A1
The present invention is directed to novel pleuroniutilin antibiotic compounds, intermediates which are useful for making these novel amibioiic compounds aad related methods and pharmaceutical compositions for treating pathogens, especia...  
WO/2018/138369A1
The present invention relates to new malodour-counteracting agents of formula (I) or stereoisomers thereof, particularly useful in blocking the olfactory perception of androstenone, Formula (I), wherein R1, R2, R3,R4, R5, R6, R7 and X ha...  
WO/2018/133705A1
The present invention relates to crystal forms of GFT-505 and a preparation method and use thereof. The provided crystal forms of GFT-505, CS1, CS2, CS5, and CS6, have high purities, good stabilities, low hygroscopicities, good solubilit...  
WO/2018/134800A1
The object of the invention are dialkyl complexes of gallium and indium having general formula I: and their use for preparing polylactide-pharmaceutically active compound conjugates and for immortal ring-opening polymerisation of heteroc...  
WO/2018/134278A1
The present invention refers to a new process for the synthesis of (9β,10α)-pregn-4-ene-3,20-dione, commonly known as retroprogesterone, having the formula (1) shown below.  
WO/2018/130865A1
A composition for treating headaches and migraines and methods of using same for preventative use to decrease the frequency, duration and severity of headaches and migraines in children and adults.  
WO/2018/119343A1
The present disclosure relates to the production of 8-methyl nonanoic acid and medium chain branched fatty acids, e.g., via microbial fermentation.  
WO/2018/116991A1
The present invention provides a method for decomposing a polyoxalate, which hydrolyzes a polyoxalate in water, and which is characterized by promoting the hydrolysis of the polyoxalate by having a chelating agent for trapping Ca ions or...  
WO/2018/112778A1
The present invention is directed to a process for synthesizing at least one levulinate ester, said process comprising a step of introducing furfuryl ether into a reaction medium and a step of conversion of furfuryl ether into levulinate...  
WO/2018/102399A1
The present invention provides indane acetic acid and their derivatives and methods for the treating and/or preventing of cognitive disorders.  
WO/2018/102358A1
The present invention provides indane acetic acid and their derivatives and methods for the treating and/or preventing of cognitive disorders based on the ApoE4 genotype of human subjects.  
WO/2018/094753A1
Disclosed is a method for preparing magnesium citrate, comprising the following steps: raw material preparation – preparation of an aqueous citric acid solution – neutralization reaction – material concentration – centrifugal deh...  
WO/2018/095973A1
A method and a system for producing glycolic acid and/or glycolate from sustainable resources.  
WO/2018/094754A1
Disclosed is a method for preparing selenium citrate, comprising the following steps: raw material preparation – preparation of an aqueous citric acid solution – neutralization reaction – material concentration – centrifugal dehy...  
WO/2018/094755A1
Disclosed is a method for preparing copper citrate, comprising the following steps: raw material preparation – preparation of an aqueous citric acid solution – neutralization reaction – material concentration – centrifugal dehydr...  
WO/2018/094757A1
Disclosed is a method for preparing anhydrous trisodium citrate, comprising the following steps: raw material preparation – preparation of a sodium hydroxide solution – neutralization reaction – material concentration – crystal p...  
WO/2018/091551A1
The present disclosure provides biostable cannabinoid compounds according to Formula I, and methods for synthesizing and enhancing the biological concentrations of the compounds, where R1, R2, and R3 are defined as set forth in the discl...  
WO/2018/090929A1
Provided is a method for biologically preparing (1R,2S)-2-(3,4-difluorophenyl)cyclopropanamine D-mandelate (I), comprising: (a) performing an asymmetric reduction reaction with a compound of formula (VI) as a substrate in the presence of...  
WO/2018/090717A1
Provided are an ATG analogue, a preparation method therefor and a use thereof, the specific structure of the ATG analogue is as shown in the following three general formulae: formula (I), formula (II), and formula (III) wherein X/Y/Z can...  
WO/2018/093135A3
The present invention relates to a method for preparing 2-hydroxy-gamma-butyrolactone through a biosynthesis pathway and, more specifically, to a method for preparing 2-hydroxy-gamma-butyrolactone from 3-hydroxypropionic acid and formic ...  

Matches 1 - 50 out of 10,593